Related Experiment Video
Updated: Feb 13, 2026

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
Published on: October 20, 2015
Digital Circulating Tumor Cell Analyses for Prostate Cancer Precision Oncology
Ellen Heitzer1,2,3, Michael R Speicher4,2
1Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
This study developed a new method to detect prostate cancer markers in circulating tumor cells (CTCs). The RNA-based digital assay identifies patients with shorter survival and predicts disease spread in prostate cancer.
Area of Science:
- Oncology
- Molecular Diagnostics
- Prostate Cancer Research
Background:
- Accurate detection of prostate cancer progression and spread is crucial for effective treatment strategies.
- Circulating tumor cells (CTCs) offer a non-invasive window into tumor biology and patient prognosis.
- Existing methods for CTC analysis have limitations in sensitivity and specificity for key cancer-related transcripts.
Purpose of the Study:
- To adapt a microfluidic CTC isolation platform (CTC-iChip) with a digital RNA-PCR readout for prostate cancer.
- To develop RNA-based digital signatures for specific prostate cancer transcripts, including androgen receptor (AR) splice variant AR-V7 and TMPRSS2-ERG translocation.
- To evaluate the clinical utility of these RNA signatures in predicting outcomes for patients with metastatic castrate-resistant prostate cancer and localized disease.
Main Methods:
- Adaptation of the microfluidic CTC-iChip platform for isolation of CTCs.
- Integration of a digital RNA-polymerase chain reaction (dRNA-PCR) assay for quantification of specific RNA transcripts.
- Analysis of eight prostate-specific transcripts, including AR-V7 and TMPRSS2-ERG, in patient blood samples.
Main Results:
- RNA-based digital CTC signatures identified patients with metastatic castrate-resistant prostate cancer initiating first-line abiraterone therapy who had shorter overall survival.
- In patients with clinically localized prostate cancer, the identified signatures were associated with seminal vesicle invasion.
- The signatures also correlated with pelvic lymph node involvement in patients with localized disease.
Conclusions:
- The developed RNA-based digital CTC assay is a promising tool for prognostic stratification in prostate cancer.
- This method can identify patients at higher risk of poor outcomes in the metastatic setting.
- The assay also shows potential for predicting local disease spread in clinically localized prostate cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Uncertainty in Measurement: Accuracy and Precision
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Overview of Pulmonary Circulation
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...

